RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

Details for Australian Patent Application No. 2006330660 (hide)

Owner Sirna Therapeutics, Inc.

Inventors Guerciolini, Roberto; Morrissey, David; Vargeese, Chandra; McSwiggen, James; Jadhav, Vasant

Agent Spruson & Ferguson

Pub. Number AU-A-2006330660

PCT Pub. Number WO2007/076328

Priority 11/510,872 25.08.06 US; 11/311,826 19.12.05 US

Filing date 18 December 2006

Wipo publication date 5 July 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/076328 Priority application(s): WO2007/076328

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006330663-Method, transaction card or identification system for transaction network

2006330655-Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof